MOREAU, PHILIPPE
 Distribuzione geografica
Continente #
NA - Nord America 462
EU - Europa 235
AS - Asia 216
SA - Sud America 18
AF - Africa 14
Totale 945
Nazione #
US - Stati Uniti d'America 459
SG - Singapore 103
GB - Regno Unito 94
CN - Cina 63
DE - Germania 39
IE - Irlanda 20
RU - Federazione Russa 19
VN - Vietnam 17
HK - Hong Kong 15
SE - Svezia 15
IN - India 14
BR - Brasile 13
IT - Italia 11
FI - Finlandia 10
FR - Francia 10
EE - Estonia 8
TG - Togo 7
UA - Ucraina 6
ZA - Sudafrica 6
AR - Argentina 3
AT - Austria 1
BH - Bahrain 1
CD - Congo 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
ID - Indonesia 1
JO - Giordania 1
JP - Giappone 1
MX - Messico 1
NL - Olanda 1
PL - Polonia 1
PR - Porto Rico 1
VE - Venezuela 1
Totale 945
Città #
Southend 88
Singapore 73
Fairfield 55
Ashburn 44
Houston 38
Santa Clara 38
Chandler 33
Woodbridge 33
Seattle 31
Cambridge 27
Wilmington 21
Dublin 20
Princeton 16
Hong Kong 14
Beijing 13
Ann Arbor 10
Boardman 8
Ho Chi Minh City 8
Nanjing 8
Westminster 8
Lomé 7
Padova 7
Buffalo 6
Munich 6
Frankfurt am Main 5
Helsinki 5
Berlin 4
Hanoi 4
Los Angeles 4
San Diego 4
Turku 4
Chicago 3
Dearborn 3
Hebei 3
Jinan 3
Norwalk 3
Redwood City 3
Saint Petersburg 3
Taiyuan 3
Bologna 2
Changsha 2
Guangzhou 2
Jiaxing 2
New York 2
Olalla 2
Portsmouth 2
Shenyang 2
Teresópolis 2
Tianjin 2
Zhengzhou 2
Amman 1
Araguari 1
Atlanta 1
Avellaneda 1
Barinas 1
Belo Horizonte 1
Buenos Aires 1
Bình Dương 1
Bắc Giang 1
Campinas 1
Costa Mesa 1
Cuautitlán Izcalli 1
Córdoba 1
Düsseldorf 1
Falkenstein 1
Forquilhinha 1
Fremont 1
Fuzhou 1
Goiânia 1
Haikou 1
Hefei 1
Kinshasa 1
Konotop 1
Lajas 1
Lanzhou 1
Lappeenranta 1
Leipzig 1
Linyi 1
Manama 1
Muizenberg 1
Nanchang 1
Nova Iguaçu 1
Orem 1
Paris 1
Pasuruan 1
Phoenix 1
Porto Velho 1
Porto da Folha 1
Pozzo 1
Provo 1
Quito 1
Quảng Ngãi 1
Redmond 1
Rio de Janeiro 1
San Francisco 1
Santo Antônio da Patrulha 1
Santo Domingo 1
Shanghai 1
Stevenage 1
São Paulo 1
Totale 738
Nome #
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study 137
Ixazomib significantly prolongs progression-free survival in high-risk relapsed/refractory myeloma patients 133
Management of relapsed multiple myeloma: Recommendations of the International Myeloma Working Group 124
Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network 122
Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma 113
Erratum to: Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma 113
Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUSTM (MM-010): a phase 3b study in refractory multiple myeloma 109
Corrigendum: Second primary malignancies in multiple myeloma: an overview and IMWG consensus 108
Totale 959
Categoria #
all - tutte 2.954
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.954


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202129 0 0 0 0 0 0 1 3 10 5 1 9
2021/2022116 6 13 9 11 12 7 4 9 3 3 19 20
2022/2023133 11 25 5 18 14 6 2 6 36 3 3 4
2023/202413 2 7 0 0 0 0 1 0 0 2 1 0
2024/2025173 1 41 7 8 51 8 5 8 3 15 1 25
2025/2026145 9 16 24 16 54 26 0 0 0 0 0 0
Totale 959